Brilinta is a brand medication that contains Ticagrelor, which belongs to a class of medications called P2Y12 receptor antagonists. It works as an antiplatelet to prevent platelets from sticking together and blood clot formation. Brilinta is therefore used for the treatment of acute coronary syndrome (CAS), acute ischemic stroke or transient ischemic attack, as well as the treatment of stable coronary artery disease (CAD), in order to prevent stroke and myocardial infarction.
The content above is informative only and not intended to be a substitute for professional medical advice, diagnosis or treatment. It should not be relied upon for specific medical advice.
Healthy Matters is Hong Kong’s leading health resource. Our mission is to help you make better health decisions and take control of your health.
Our team of experts is committed to producing reliable health content that is accurate, engaging and relevant, to cover your health & wellness journey from prevention to treatment.
Whether you are looking for trusted information on health conditions, wellbeing or looking for the right doctor or service in Hong Kong, we’re here to help!
Your health matters. Begin your health journey with Healthy Matters today!